Publications by authors named "Wanida Ruangsiriluk"

Claim this Profile
I
Intravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II Mice.
Wanida Ruangsiriluk, Sarah Melissa P Jacobo, Andrea Iskenderian, Meera Modi, Nancy Chen

Hum Gene Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volumetric MRI of dorsal root ganglia as a biomarker for disease progression and response to AAV treatment in a mouse model of Fabry disease.
Fuqiang Zhao, Shipeng Yuan, Charalambos Kaittanis, Mugdha Deshpande, Abirami Kugadas, Wanida Ruangsiriluk

PLoS One· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal imaging of therapeutic enzyme expression after gene therapy for Fabry disease using positron emission tomography and the radiotracer [F]AGAL.
Charalambos Kaittanis, Tyler Teceno, Ashley Knight, Yoann Petibon, Phil Sandoval, Wanida Ruangsiriluk

Mol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiosynthesis and in vivo evaluation of [F]BEAN as a potential mitochondria-based PET biomarker for metabolic disorders.
Charalambos Kaittanis, Hyunjung Kim, Tyler Teceno, Yoann Petibon, Ashley Knight, Wanida Ruangsiriluk

Bioorg Med Chem Lett· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversing Pathology in an Aggravated Fabry Mouse Model Using Low-Dose Engineered Human Alpha-Galactosidase A AAV Gene Therapy.
Wanida Ruangsiriluk, Mugdha Deshpande, Natalia Boukharov, Girija Rajarshi, Shreya Mukherji

Biomedicines· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac manifestations of Fabry disease in G3Stg/GlaKO and GlaKO mouse models-Translation to Fabry disease patients.
Abirami Kugadas, Pietro Artoni, Wanida Ruangsiriluk, Meng Zhao, Natalia Boukharov

PLoS One· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiosynthesis and Early Evaluation of a Positron Emission Tomography Imaging Probe [F]AGAL Targeting Alpha-Galactosidase A Enzyme for Fabry Disease.
Talakad G Lohith, Charalambos Kaittanis, Anthony P Belanger, Shin Hye Ahn, Phil Sandoval, Wanida Ruangsiriluk

Molecules· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation.
Donna N Petersen, Julie Hawkins, Wanida Ruangsiriluk, Kimberly A Stevens, Bruce A Maguire

Cell Chem Biol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a selective activity-based probe for glycosylated LIPA.
Adam G Schwaid, Wanida Ruangsiriluk, Allan R Reyes, Shawn Cabral, Francis Rajamohan

Bioorg Med Chem Lett· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
Francis Rajamohan, Allan R Reyes, Wanida Ruangsiriluk, Lise R Hoth, Seungil Han

Protein Expr Purif· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing of enzymes involved in ceramide biosynthesis causes distinct global alterations of lipid homeostasis and gene expression.
Wanida Ruangsiriluk, Shaun E Grosskurth, Daniel Ziemek, Max Kuhn, Shelley G des Etages

J Lipid Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis